Latest News
N-ABLE INC (NYSE:NABL) reported strong Q2 2025 results, beating revenue and EPS estimates with $131.2M in sales and $0.11 non-GAAP EPS. Stock rose 6.7% pre-market.
Via Chartmill · August 7, 2025
The company is still in the early stages of adding patients with type 2 diabetes to its client base.
Via Investor's Business Daily · August 7, 2025
KVHI reports mixed Q2 2025 earnings, missing revenue estimates but beating EPS with $0.03. Stock rises 5% pre-market as investors focus on profitability.
Via Chartmill · August 7, 2025
Nexstar Media Group (NXST) reported Q2 2025 earnings with $1.23B revenue (slight miss) but beat EPS estimates at $3.06. Shares rose modestly as cost cuts offset ad declines. Political ad rebound expected in 2026.
Via Chartmill · August 7, 2025
Toyota Warns Higher US Tariff Impact For FY26: Retail Sees No Reason To Cheerstocktwits.com
Via Stocktwits · August 7, 2025
Liberty Latin America (LILA) Q2 2025 earnings miss revenue and EPS estimates, with a $423M net loss. Adjusted OIBDA rose 7% YoY, but stock fell 2.23% pre-market. Plans to spin off Puerto Rico operations.
Via Chartmill · August 7, 2025
Achieve Life Sciences reports Q2 2025 results with $0.0 revenue and -$0.37 EPS, meeting estimates. Shares rise 2.3% pre-market as focus remains on cytisinicline development for smoking cessation.
Via Chartmill · August 7, 2025
Eli Lilly shares plunged in premarket trading after disappointing results from its new weight-loss drug overshadowed strong second-quarter results and raised full-year guidance.
Via Talk Markets · August 7, 2025
Ligand Pharmaceuticals (LGND) beat Q2 2025 earnings estimates with strong royalty growth, raising full-year guidance. Stock dipped slightly pre-market but gained 16.3% over the past month.
Via Chartmill · August 7, 2025
Martin Marietta Materials (MLM) posted mixed Q2 2025 results, with EPS beating estimates but revenue missing. Shares dipped as investors weighed strong cost controls against sales pressures.
Via Chartmill · August 7, 2025
Immunocore (IMCR) beat Q2 2025 estimates with $98M revenue (+30% YoY) and a narrower EPS loss. KIMMTRAK sales surged 32%, while pipeline progress and strong cash position ($882.8M) boosted investor confidence.
Via Chartmill · August 7, 2025
SharkNinja reports strong Q2 2025 results, beating revenue and EPS estimates. Raised full-year guidance reflects confidence in growth, with shares surging 8% pre-market.
Via Chartmill · August 7, 2025
Ironwood Pharmaceuticals Q2 2025 earnings beat estimates with $85.24M revenue and $0.14 EPS, driven by LINZESS growth and pipeline progress. Shares surged 19.25% pre-market.
Via Chartmill · August 7, 2025
Palantir delivered another blowout earnings report, sending the stock higher.
Via The Motley Fool · August 7, 2025
There's no sign of any slowdown in the AI/data center market in 2025.
Via The Motley Fool · August 7, 2025
Phathom Pharmaceuticals (PHAT) beats Q2 revenue and EPS estimates, driven by strong VOQUEZNA adoption. Shares rise 6.2% premarket as company narrows losses and raises full-year guidance.
Via Chartmill · August 7, 2025
Priority Technology Holdings (PRTH) reported mixed Q2 2025 results, missing revenue estimates ($239.8M vs. $243.9M) but beating EPS ($0.26 vs. $0.21). Shares rose 7% pre-market as strong margins and raised guidance offset sales concerns.
Via Chartmill · August 7, 2025
Pagaya Technologies (PGY) Q2 2025 earnings beat estimates with $326.4M revenue & $0.64 EPS, driving a 13% pre-market stock surge. Strong growth in network volume & profitability.
Via Chartmill · August 7, 2025
Via Benzinga · August 7, 2025
Shopify affirmed its robust growth outlook, catalyzing a 15% stock price increase that set the market up for a run to $200.
Via MarketBeat · August 7, 2025
Kaltura (KLTR) reported mixed Q2 2025 earnings, with revenue slightly missing estimates but EPS beating expectations, turning a profit. Stock rose 3.5% pre-market.
Via Chartmill · August 7, 2025
An analyst called the unexpected flop a "once-in-a-blue-moon" occasion for Eli Lilly's dominant weight-loss franchise.
Via Investor's Business Daily · August 7, 2025
Via Benzinga · August 7, 2025
Warner Bros. Discovery beats Q2 EPS estimates with $0.63 vs. expected loss, revenue slightly misses. Shares rise 3.28% pre-market on profit turnaround.
Via Chartmill · August 7, 2025
Via Benzinga · August 7, 2025
Check out the companies making headlines yesterday:
Via StockStory · August 7, 2025
GOGO INC beats Q2 2025 estimates with $226M revenue, up 121% YoY. Adjusted EBITDA hits $61.7M, net income $12.8M. Raises full-year guidance, confirms 5G rollout for Q4. Stock up slightly pre-market.
Via Chartmill · August 7, 2025
The company's valuation is now north of $21 billion, and it trades at close to 50 times its revenue.
Via The Motley Fool · August 7, 2025
Taiwan Mobile Company Limited was founded in 1997 and is the second-largest telecom service provider in Taiwan.
Via Talk Markets · August 7, 2025
Insulet Corp. (PODD) reported strong Q2 2025 earnings, beating revenue and EPS estimates with $649.1M in sales and $1.17 adjusted EPS. Stock rose 4.58% pre-market. Raised full-year guidance signals growth confidence.
Via Chartmill · August 7, 2025
Altice USA (NYSE:ATUS) Q2 2025 earnings miss estimates with $2.15B revenue and $0.21 EPS loss. Shares drop as broadband declines offset fiber and mobile growth.
Via Chartmill · August 7, 2025
BARK Inc reported mixed Q1 FY2026 results, with revenue beating estimates at $102.9M but EPS missing at -$0.02. Shares rose 4.18% pre-market as net losses narrowed and Commerce revenue grew 49.5%. Outlook remains cautious amid tariff uncertainties.
Via Chartmill · August 7, 2025
Datadog (DDOG) beats Q2 2025 estimates with $826.8M revenue (+28% YoY) and $0.46 EPS. Stock surges 12.6% pre-market. Strong outlook and product innovation drive growth.
Via Chartmill · August 7, 2025
Kelly Services (KELYA) Q2 2025 earnings miss estimates with $1.10B revenue and $0.54 EPS. Shares drop 1.63% pre-market amid 10.12% two-week decline. New CEO appointed.
Via Chartmill · August 7, 2025